Nihal Purohit

Mr. Nihal Purohit

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KKKatarzyna Kępka
Katarzyna Kępka
KCKatarzyna Aneta Chałaśkiewicz
Katarzyna Aneta Chałaśkiewicz
MOMagdalena Ogłuszka
Magdalena Ogłuszka
MBMateusz Borkowski
Mateusz Borkowski
ALAdam Lepczyński
Adam Lepczyński
MPMariusz Pierzchała
Mariusz Pierzchała
Aflatoxins, toxic secondary metabolites produced primarily by Aspergillus flavus and Aspergillus parasiticus, pose a significant global health concern due to their frequent presence in crops, food, and feed—especially under climate change conditions. This review addresses the growing threat of aflatoxins by analyzing recent advances in detection and mitigation. A comprehensive literature review was conducted, focusing on bioremediation, physical and chemical detoxification, and fungal growth inhibition strategies. The occurrence of aflatoxins in water systems was also examined, along with current detection techniques, removal processes, and regulatory frameworks. Emerging technologies such as molecular diagnostics, immunoassays, biosensors, and chromatographic methods are discussed for their potential to improve monitoring and control. Key findings highlight the increasing efficacy of integrative approaches combining biological and technological solutions and the potential of AI-based tools and portable devices for on-site detection. Intelligent packaging and transgenic crops are also explored for their role in minimizing contamination at the source. Overall, this review emphasizes the importance of continued interdisciplinary research and the development of sustainable, adaptive strategies to mitigate aflatoxin risks, thereby supporting food safety and public health in the face of environmental challenges.

Verified
Journal Article
Open access
PDF file
KCKatarzyna Aneta Chałaśkiewicz
Katarzyna Aneta Chałaśkiewicz
KKKatarzyna Kępka
Katarzyna Kępka
RSRafał Radosław Starzyński
Rafał Radosław Starzyński
MOMagdalena Ogłuszka
Magdalena Ogłuszka
MBMateusz Borkowski
Mateusz Borkowski
MPMariusz Pierzchała
Mariusz Pierzchała
Aflatoxins, toxic secondary metabolites produced by Aspergillus species, are widespread contaminants in food and feed, with aflatoxin B1 (AFB1) recognized as the most potent carcinogen. Climate change increases the risk of contamination by promoting fungal proliferation. While the hepatotoxic and enterotoxic effects of aflatoxins are well established, emerging evidence highlights their immunosuppressive and neurotoxic potential. Notably, AFB1 disrupts gut microbiota, compromises intestinal barrier integrity, and induces neuroinflammation via the microbiota–gut–brain axis. Probiotics have shown promise in mitigating these effects by modulating microbial balance, enhancing barrier function, and reducing neuroinflammatory responses. This review summarizes current findings on the systemic toxicity of aflatoxins—particularly their impact on the gut–brain axis—and evaluates the therapeutic potential of probiotics in counteracting aflatoxin-induced damage.

18 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Prarthana SharmaPrarthana Sharma
Prarthana Sharma
Varunkumar AsediyaVarunkumar Asediya
Varunkumar Asediya
GKGarima Kalra
Garima Kalra
Sharmin SultanaSharmin Sultana
Sharmin Sultana
NPNihal Purohit
Nihal Purohit
MPMariusz Pierzchała
Mariusz Pierzchała
Silymarin, a flavonolignan-rich extract of Silybum marianum, is widely recognized for its hepatoprotective potential. While rodent studies predominate, pigs (Sus scrofa) offer a more translationally relevant model due to their hepatic architecture, bile acid composition, and transporter expression, which closely resemble those of humans. This narrative review synthesises current evidence on the chemistry, pharmacokinetics, biodistribution, and hepatoprotective activity of silymarin in porcine models. Available studies demonstrate that when adequate intrahepatic exposure is achieved, particularly through optimised formulations, silymarin can attenuate oxidative stress, suppress inflammatory signalling, stabilise mitochondria, and modulate fibrogenic pathways. Protective effects have been reported across diverse porcine injury paradigms, including toxin-induced necrosis, ethanol- and diet-associated steatosis, metabolic dysfunction, ischemia–reperfusion injury, and partial hepatectomy. However, the evidence base remains limited, with few long-term studies addressing fibrosis or regeneration, and methodological heterogeneity complicates the comparison of data across studies. Current knowledge gaps in silymarin research include inconsistent chemotype characterization among plant sources, limited reporting of unbound pharmacokinetic parameters, and variability in histological scoring criteria across studies, which collectively hinder cross-study comparability and mechanistic interpretation. Advances in analytical chemistry, transporter biology, and formulation design are beginning to refine the interpretation of exposure–response relationships. Advances in analytical chemistry, transporter biology, and formulation design are beginning to refine the interpretation of exposure–response relationships. In parallel, emerging computational approaches, including machine-learning-assisted chemotype fingerprinting, automated histology scoring, and Bayesian exposure modeling, are being explored as supportive tools to enhance reproducibility and translational relevance; however, these frameworks remain exploratory and require empirical validation, particularly in modeling enterohepatic recirculation. Collectively, current porcine evidence supports silymarin as a context-dependent yet credible hepatoprotective agent, highlighting priorities for future research to better define its therapeutic potential in clinical nutrition and veterinary practice.

26 January 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
KKKamila Kibitlewska
Kamila Kibitlewska
Varunkumar AsediyaVarunkumar Asediya
Varunkumar Asediya
KKKrzysztof Karpiesiuk
Krzysztof Karpiesiuk
UCUrszula Czarnik
Urszula Czarnik
MLMarek Lucjusz Lecewicz
Marek Lucjusz Lecewicz
WKWojciech Kozera
Wojciech Kozera
Curcumin, the major polyphenolic constituent of Curcuma longa, has been widely investigated as a hepatoprotective adjunct due to its antioxidant and immunomodulatory properties. This review evaluates the relevance of curcumin for the prevention and management of liver dysfunction and hepatitis in pigs by synthesizing available porcine evidence and integrating mechanistic insights from translational liver injury models where pig-specific data remain limited. Across experimental hepatic injury contexts, curcumin administration is most consistently associated with reduced biochemical and structural indicators of hepatocellular damage, including decreased aminotransferase activity, attenuation of lipid peroxidation, and enhancement of endogenous antioxidant defenses. These effects are mechanistically linked to suppression of pro-inflammatory signaling pathways, particularly NF-κB-related transcriptional activity and inflammasome-associated responses, together with reduced expression of key cytokines such as TNF-α, IL-1β, and IL-6. Concurrent activation of Nrf2-centered cytoprotective pathways and induction of phase II antioxidant enzymes (including HO-1, GST, and NQO1) appear to constitute a conserved axis supporting hepatic oxidative stress resilience. In swine-relevant infectious settings, available data further support antiviral activity against selected porcine pathogens, including classical swine fever virus and porcine reproductive and respiratory syndrome virus, potentially mediated through interference with lipid-dependent stages of viral replication and modulation of Kupffer cell activation. Although combination strategies with established hepatoprotective approaches are conceptually attractive, current synergy evidence remains heterogeneous and largely extrapolated. Overall, curcumin represents a plausible adjunct candidate for supporting porcine liver health; however, translation into practice will depend on resolving formulation-dependent bioavailability constraints and strengthening the pig-specific evidence base.

19 March 2026 in Translational Research in Veterinary Science
Verified
Journal Article
Open access
NPNihal Purohit
Nihal Purohit
Aflatoxin B1 (AFB1), a potent mycotoxin produced by Aspergillus species, poses significant threats to livestock health and food safety, particularly in swine production. AFB1-induced hepatotoxicity involves complex molecular mechanisms including cytochrome P450-mediated bioactivation, oxidative stress, inflammatory responses, and disrupted cellular homeostasis. Dietary supplementation with Curcuma longa extract (curcumin) has emerged as a promising hepatoprotective intervention, demonstrating efficacy through multiple molecular pathways including inhibition of phase-I bioactivation, activation of Nrf2-driven antioxidant responses, anti-inflammatory effects, and restoration of autophagy. While bulk transcriptomic studies in porcine models have revealed broad gene expression changes, single-cell RNA sequencing (scRNA-seq) offers unprecedented resolution to dissect cell-type-specific responses in the heterogeneous liver microenvironment. This review synthesizes current evidence on AFB1 hepatotoxicity mechanisms, curcumin's hepatoprotective pathways, and the transformative potential of scRNA-seq technology to resolve cellular heterogeneity in porcine liver responses to mycotoxin exposure and dietary intervention. We highlight the critical role of porcine-specific cytochrome P450 2A19 in AFB1 bioactivation, intercellular communication via extracellular vesicles in fibrogenesis, and the methodological advances enabling single-cell transcriptomic in primary porcine hepatocytes. This synthesis provides a roadmap for future scRNA-seq studies to definitively map cell-type-specific protective mechanisms of curcumin against AFB1 hepatotoxicity in swine.

17 November 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
CPChandra Shekhar Pareek
Chandra Shekhar Pareek
Michał ZłochMichał Złoch
Michał Złoch
Paweł PomastowskiPaweł Pomastowski
Paweł Pomastowski
JWJustyna Walczak-Skierska
Justyna Walczak-Skierska
JRJoanna Rudnicka
Joanna Rudnicka
Klaus WimmersKlaus Wimmers
Klaus Wimmers
Commercial botanical extracts are used as dietary antioxidants, but their activity depends on the declared marker, co-extracted phenolics, and the assay used. We characterized standardized commercial extracts of Andrographis paniculata, Silybum marianum, and Curcuma longa and a silymarin tablet by HPLC-ESI-MS/MS, HPLC-UV, spectrophotometric assays, and GC/MS. Markers were identified against authentic standards and quantified as 248.91 ± 6.12 mg/g andrographolide, 737.14 ± 20.31 mg/g silybin-equivalents, and 870.39 ± 6.41 mg/g curcumin; the tablet contained 66.59 ± 1.96 mg silybin-equivalents (95.13% of the declared 70 mg). Redissolution in 70% ethanol rather than boiling water increased the Folin–Ciocalteu and aluminum-complexation responses most strongly for C. longa and S. marianum (botanical × solvent interaction, p < 0.001), but in C. longa, these responses largely reflect curcuminoid solubility and assay interference rather than polyphenol recovery. Antioxidant capacity measured by DPPH followed botanical-specific patterns that were not proportional to total phenolic response. HPLC-UV fingerprints differed between preparation media, although several retention-time assignments required mass-spectrometric confirmation. Commercial antioxidant extracts should therefore be characterized by marker-specific quantification, more than one antioxidant assay, and compositional data obtained in the same preparation medium.